Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Activin receptor type-1 |
---|
Ligand | BDBM604492 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Biochemical assay |
---|
IC50 | >1000±n/a nM |
---|
Citation | Kotian, PL; Babu, YS; Kumar, VS; Zhang, W; Lu, P; Raman, K Imidazole-containing inhibitors of ALK2 kinase US Patent US11661426 Publication Date 5/30/2023 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Activin receptor type-1 |
---|
Name: | Activin receptor type-1 |
Synonyms: | 2.7.11.30 | ACTR-I | ACVR1 | ACVR1_HUMAN | ACVRLK2 | ALK-2 | ALK2/ACVR1 | Activin receptor type I | Activin receptor-like kinase 2 | Activin receptor-like kinase 2 (ALK-2) | Activin receptor-like kinase 2 (ALK2/ACVR1) | Q04771 | SKR1 | Serine/threonine-protein kinase receptor R1 | TGF-B superfamily receptor type I | TSR-I |
Type: | n/a |
Mol. Mass.: | 57158.32 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 509 |
Sequence: | MVDGVMILPVLIMIALPSPSMEDEKPKVNPKLYMCVCEGLSCGNEDHCEGQQCFSSLSIN
DGFHVYQKGCFQVYEQGKMTCKTPPSPGQAVECCQGDWCNRNITAQLPTKGKSFPGTQNF
HLEVGLIILSVVFAVCLLACLLGVALRKFKRRNQERLNPRDVEYGTIEGLITTNVGDSTL
ADLLDHSCTSGSGSGLPFLVQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR
DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL
DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM
HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS
NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ
NPSARLTALRIKKTLTKIDNSLDKLKTDC
|
|
|
BDBM604492 |
---|
n/a |
---|
Name | BDBM604492 |
Synonyms: | (S)-5-(4-((2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)amino)-1H-imidazol-1-yl)-2,3-dimethoxybenzonitrile | US11661426, Compound 167f |
Type | Small organic molecule |
Emp. Form. | C23H24N8O3 |
Mol. Mass. | 460.4885 |
SMILES | COc1cc(cc(C#N)c1OC)-n1cnc(Nc2nc(nn3cccc23)N2CCC[C@H]2CO)c1 |
Structure |
|